FDA review summary: Mozobil in combination with granulocyte colony-stimulating factor to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation (Q33446708)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | FDA review summary: Mozobil in combination with granulocyte colony-stimulating factor to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation |
scientific article |
Statements
1 reference
FDA review summary: Mozobil in combination with granulocyte colony-stimulating factor to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation (English)
1 reference
Michael Brave
1 reference
Ann Farrell
1 reference
Sue Ching Lin
1 reference
Terrance Ocheltree
1 reference
Sarah Pope Miksinski
1 reference
Shwu-Luan Lee
1 reference
Haleh Saber
1 reference
Jeanne Fourie
1 reference
Christoffer Tornoe
1 reference
Brian Booth
1 reference
Weishi Yuan
1 reference
Kun He
1 reference
Robert Justice
1 reference
Richard Pazdur
1 reference
Identifiers
1 reference